All News about Ocugen Inc
Ocugen Announces Completion of Dosing in OCU400 Phase 1/2 Cohort 2
October 12, 2022
From Ocugen
Via GlobeNewswire
Via Benzinga
Ocugen Inks US Development Pact For Its Intranasal COVID-19 Vaccine
September 28, 2022
Via Benzinga
From Ocugen
Via GlobeNewswire
Ocugen, Inc. to Present at Chardan’s 6th Annual Genetic Medicines Conference
September 29, 2022
From Ocugen
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|